Related Experiment Video
Updated: Dec 20, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Stigmasterol Causes Ovarian Cancer Cell Apoptosis by Inducing Endoplasmic Reticulum and Mitochondrial Dysfunction
Hyocheol Bae1, Gwonhwa Song1, Whasun Lim2
1Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Background:
Phytosterols have physiological effects and are used as medicines or food supplements. Stigmasterol has shown anticancer effects against various cancers such as hepatoma, cholangiocarcinoma, gall bladder carcinoma, endometrial adenocarcinoma and skin, gastric, breast, prostate, and cervical cancer. However, there are no reports on stigmasterol's effects on ovarian cancer.
Methods:
We investigated the effects of stigmasterol on proapoptotic signals, mitochondrial function, reactive oxygen species production, and the cytosolic and mitochondrial calcium levels in human ovarian cancer cells, to understand the mechanisms underlying the effects of stigmasterol on ovarian cancer cells. We also conducted migration assay to confirm whether that stigmasterol inhibits ovarian cancer cell migration.
Results:
Stigmasterol inhibited development of human ovarian cancer cells. However, it induced cell apoptosis, ROS production, and calcium overload in ES2 and OV90 cells. In addition, stigmasterol stimulated cell death by activating the ER-mitochondrial axis. We confirmed that stigmasterol suppressed cell migration and angiogenesis genes in human ovarian cancer cells.
Conclusions:
Our findings suggest that stigmasterol can be used as a new treatment for ovarian cancer.
Insights
Stigmasterol, a phytosterol, effectively inhibits ovarian cancer cell growth and migration. It induces apoptosis and cell death by activating the ER-mitochondrial axis, suggesting its potential as a novel ovarian cancer treatment.
Area of Science:
- Phytochemistry
- Oncology
- Cell Biology
Background:
- Phytosterols, like stigmasterol, possess physiological benefits and are utilized in medicine and supplements.
- Stigmasterol exhibits anticancer properties against numerous cancer types, but its impact on ovarian cancer remains unexplored.
Purpose of the Study:
- To investigate the effects of stigmasterol on human ovarian cancer cells.
- To elucidate the mechanisms of stigmasterol's action, including its impact on apoptosis, mitochondrial function, reactive oxygen species (ROS), and calcium levels.
Main Methods:
- Examined proapoptotic signals, mitochondrial function, ROS production, and cytosolic/mitochondrial calcium levels in ovarian cancer cells.
- Utilized migration assays to assess stigmasterol's effect on cell motility.
- Analyzed the activation of the ER-mitochondrial axis in response to stigmasterol treatment.
Main Results:
- Stigmasterol demonstrated inhibitory effects on human ovarian cancer cell development.
- The compound induced apoptosis, ROS production, and calcium overload in ES2 and OV90 ovarian cancer cell lines.
- Stigmasterol activated the ER-mitochondrial axis, leading to cell death and suppressed cell migration and angiogenesis genes.
Conclusions:
- Stigmasterol exhibits significant anti-ovarian cancer activity.
- The compound induces cancer cell death through apoptosis and ER-mitochondrial axis activation.
- Stigmasterol presents potential as a novel therapeutic agent for ovarian cancer treatment.
Related Concept Videos
Oogenesis
The Intrinsic Apoptotic Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Extrinsic Apoptotic Pathway

